Altace Related Clinical Trials
Bioavailability Study of Ramipril 10 mg Capsules of Dr. Reddy's Laboratories Limited Under Fasting Conditions [Completed]
Bioavailability Study of Ramipril 10 mg Capsules of Dr. Reddy's Laboratories Limited, Under Non-Fasting Conditions [Completed]
Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy [Recruiting]
Mechanisms of Ramipril Reduction in the Onset of Type 2 Diabetes [Terminated]
Efficacy of Aliskiren Compared to Ramipril in the Treatment of Moderate Systolic Hypertensive Patients [Completed]
Efficacy and Safety of Aliskiren/Ramipril/Amlodipine Compared With Ramipril/Amlodipine and Aliskiren/Amlodipine in Patients With Metabolic Syndrome [Terminated]
Safety and Efficacy of Aliskiren 300 mg, 150 mg and 75 mg in Patients With Essential Hypertension Compared to Ramipril 5 mg [Completed]
Bioequivalence of Telmisartan / Ramipril Fixed Dose Combination Compared With the Monocomponents Given Concomitantly to Healthy Male and Female Volunteers [Completed]
Effects of Aliskiren, Ramipril, and the Combination on Levels of Angiotensin II in Patients With Decompensated Systolic Heart Failure [Completed]
Bioequivalence of Telmisartan/g Ramipril Fixed Dose Combination Compared With the Monocomponents Telmisartan and Ramipril (Two Different Formulations) Given Concomitantly to Healthy Male and Female Volunteers [Completed]
Comparison of Awakening Versus Bedtime Dosing of Ramipril in Subjects With Essential Hypertension [Completed]
Bioequivalence Study of Ramipril 10 mg Capsules Under Fed Conditions [Completed]
Efficacy and Safety Study of Azilsartan Medoxomil Compared to Ramipril for Treating Essential Hypertension [Completed]
Ramipril for the Treatment of Oligospermia [Recruiting]
Relative Bioavailability of Empagliflozin (BI 10773) and Ramipril Administered Together Compared to Empagliflozin (BI 10773) and Ramipril Alone in Healthy Volunteers [Completed]
A Study of the Effectiveness and Safety of Ramipril in the Treatment of Hypertension in Children and Adolescents [Terminated]
Bioequivalence Study of Ramipril 10 mg Capsules Under Fasting Conditions [Completed]
Ramipril 10 mg Capsule in Healthy Subjects Under Fed Conditions [Completed]
Ramipril 10 mg Capsule in Healthy Subjects Under Fasting Conditions [Completed]
Ramipril 10 mg Capsule in Healthy Subjects Under Fasting Conditions [Completed]
A Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fasting Conditions [Completed]
A Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fed Conditions [Completed]
A Relative Bioavailability Study of Ramipril 10 mg Capsules Administered Orally as a Sprinkle on Applesauce [Completed]
An Open-labeled Trial of Ramipril in Patients With Migraine [Completed]
Steady State Pharmacokinetics of Telmisartan, Ramipril or the Combination Following Repeated Oral Doses to Healthy Male and Female Volunteers [Completed]
Compare the Effect of Aliskiren Plus Valsartan Versus Angiotensin-Converting Enzyme Inhibitor (ACEi) Plus Angiotensin Receptor Blocker (ARB) [Ramipril Plus Telmisartan] on the Renin-Angiotensin-Aldosterone System (RAAS) in Hypertensive Patients [Completed]
REducing Blood Pressure Variability in Essential Hypertension With RAmipril vErsus Nifedipine GITS Trial [Not yet recruiting]
Left Atrial Remodelling in Hypertension: Effects of Ramipril or Irbesartan [Recruiting]
Studying the Effects of Antihypertensives on Individuals at Risk for Alzheimer's [Completed]
Ramipril 10 mg/Day Prevention [Completed]
To Study the Effects of Aliskiren on Albuminuria and Various Biomarkers in Patients With Nephropathy [Terminated]
Clinical and Cost Effectiveness of ACE Inhibitor, Ramipril, in Intermittent Claudicants [Completed]
To Demonstrate the Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fasting Conditions [Completed]
To Demonstrate the Relative Bioavailability Study of Ramipril 10 mg Capsules Under Non-Fasting Conditions [Completed]
Renin Angiotensin Aldosterone System (RAAS) and Fibrinolysis in Humans: ACEi and PE5i [Completed]
Antiproteinuric Effect of Imidapril Versus Ramipril in Type 2 Diabetic and Hypertensive Patients With Microalbuminuria [Recruiting]
Ramipril Versus Carvedilol in Duchenne and Becker Patients [Recruiting]
Efficacy Study of Pioglitazone and Ramipril Combination Therapy in Treating Non-diabetic Hypertensive Patients. [Completed]
Influence of Food on the Bioavailability of Telmisartan / Ramipril Fixed Dose Combination in Healthy Male and Female Volunteers [Completed]
HYZAAR vs. Ramipril for Diabetes (0954A-245)(COMPLETED) [Completed]
Gene Expression Profiling in Skeletal Muscle of Healthy Subjects Treated With Ramipril [Completed]
Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors [Terminated]
Impact of Diabetes on Left Ventricular Remodeling [Completed]
Efficacy and Safety Study to Delay Renal Failure in Children With Alport Syndrome [Recruiting]
Aliskiren Versus Ramipril on Antiproteinuric Effect in Hypertensive, Type 2 Diabetic Patients With Microalbuminuria [Recruiting]
Efficacy of Telmisartan and the Combination of Telmisartan and Ramipril in type1 Diabetes Patients With Nephropathy [Completed]
Study Evaluating The Effect Of Ramipril On Urinary Protein Excretion In Renal Transplant Patients Converted To Sirolimus [Completed]
Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria [Completed]
China Medical University Hospital (CMUH) Triapin Listing [Completed]
The Study of Atherosclerosis With Ramipril and Rosiglitazone [Completed]
PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTN [Completed]
The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) Trial [Completed]
Treatment of Pediatric Hypertension With Altace Trial [Completed]
A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Blood Pressure [Terminated]
Use of Ramipril and Felodipine Combination Therapy in Hypertension: An Effectiveness Study With Local Patients in Argentina [Completed]
Study of Inflammation and Oxidative Stress in Persons Undergoing Dialysis [Completed]
Telmisartan Versus Ramipril After Acute Coronary Syndrome [Recruiting]
Telmisartan (Micardis) and Ramipril (Altace) - Factorial Design Study for the Treatment of Hypertension [Completed]
Pharmacodynamic Clinical Trial of Cardiovascular Polypill on LDL Cholesterol [Terminated]
Higher Dose of Ramipril Versus Addition of Telmisartan-Ramipril in Hypertension and Diabetes [Terminated]
Impact of Body Composition on Bisoprolol and Ramipril Pharmacokinetics in Patients With Chronic Heart Failure [Recruiting]
Prospective Randomised Investigation of the Safety and Efficacy of Micardis® vs Ramipril Using ABPM [Completed]
The Study of Novel Dual Renin Angiotensin Aldosterone System (RAAS) Blockade; Valsartan/Aliskiren in African American Patients With Hypertension and the Metabolic Syndrome [Withdrawn]
Bioequivalency Study of Ramipril 10 mg Capsules Under Fed Conditions [Completed]
Bioequivalency Study of Ramipril 10 mg Capsules Under Fasting Conditions [Completed]
The Effects of Ramipril on Clinical Symptoms in Patients With Peripheral Arterial Disease [Completed]
Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension [Completed]
Ramipril - Hypertension [Completed]
Genes, Fibrinolysis and Endothelial Dysfunction- Dialysis Aim 3 [Terminated]
Statin and Angiotensin-converting Enzyme Inhibitor on Symptoms in Patients With SCAD [Recruiting]
Trial to Compare the Effects of Either Telmisartan (40-80 mg PO Once Daily) or Ramipril (5-10 mg PO Once Daily) on Renal Endothelial Dysfunction in Hypertensive Patients With Type 2 Diabetes [Completed]
Safety and Efficacy of Ramipril in the Treatment of Essential Hypertension [Active, not recruiting]
FGF-23 and Endothelial Dysfunction in Diabetic Proteinuric Patients [Completed]
A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Low Density Lipoprotein (LDL) Cholesterol [Terminated]
A Clinical Study to Compare an Aliskiren Based Hypertensive Regimen With a Ramipril Based One Followed by a Randomized Withdrawal. [Completed]
Safety and Effects of Ramipril Combined With Candesartan [Completed]
FOCUS:Focus On Coronary Unstable Syndromes [Completed]
Angiotensin Converting Enzyme (ACE) Inhibition and Peripheral Arterial Disease [Completed]
Angiotensin Converting Enzyme (ACE) Inhibition and Cardiac Allograft Vasculopathy [Active, not recruiting]
To Investigate the Effect of Rosiglitazone and Ramipril on Pre-clinical Vasculopathy in Diabetes and IGT Patients [Completed]
The Effect of Renin Angiotensin System Blockage (RAS) Blockade On PTX3 Levels In Diabetic Patients With Proteinuria [Completed]
Sevelamer in Proteinuric CKD [Recruiting]
Cardiotoxicity Prevention in Breast Cancer Patients Treated With Anthracyclines and/or Trastuzumab [Recruiting]
Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel Inflammation [Completed]
A Clinical Study to Evaluate the Safety and Efficacy of Aliskiren Alone and in Combination With Ramipril in Hypertensive, Diabetic Patients. [Completed]
Effect of ACE-Inhibition on Microvascular Function in Women With Assessed Microvascular Dysfunction [Enrolling by invitation]
Effects of Sodium Intake on (PK/PD) Relationship of a Single Dose of a Renin Angiotensin System-Blocker [Completed]
Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plus Sibutramine Versus Placebo in Obese Hypertensives [Completed]
Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor [Completed]
Efficacy and Safety of Aliskiren 300mg Compared to Irbesartan 300mg and Ramipril 10 mg in the Setting of a Missed Dose for Patients With Essential Hypertension. [Completed]
Treatment of Early Immunoglobulin A Nephropathy by Angiotensin Converting Enzyme Inhibitor - A Randomized Controlled Trial [Completed]
Efficacy and Safety of the Combination of Valsartan Plus Amlodipine in Hypertensive Patients Not Adequately Responding to the Combination Therapy With Ramipril Plus Felodipine [Completed]
Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery [Not yet recruiting]
Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts [Active, not recruiting]
|